Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)
Completed
- Conditions
- Angioedema
- Interventions
- Other: Quality of life
- Registration Number
- NCT03240991
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Brief Summary
This study aims to describe quality of life in hereditary or acquired non drug-related bradykinin-mediated angioedema patients, using validated questionnaires
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
- Clinically documented angioedema due to C1 inhibitor deficiency, hereditary (type I et II) or acquired
- Clinically documented angioedema with normal C1 inhibitor activity (hereditary type III)
Exclusion Criteria
- Acquired angioedema with normal C1 inhibitor activity (former "drug-induced")
- Minor subjects
- Vulnerable subjects (under guardianship/curatorship/tutorship)
- Pregnant women
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Quality of life questionnaires Quality of life Data will be collected retrospectively and prospectively.
- Primary Outcome Measures
Name Time Method Dermatology Life Quality Index (DLQI) 6 months Description of Quality of Life (QoL) using DLQI
Angioedema Quality of Life (AE-QoL) Questionnaire 6 months Description of QoL using AE-QOL questionnnaire
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU Besançon
🇫🇷Besançon, France